Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Novel in vitro model for estrogen (e) stimulated cancers applied to screening dicathis orbita derived bioactive molecules and synthetic analogues for anti-cancer activity

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Poster
  • By: YOUNG, Fiona Margaret (Flinders University, Medical Biotechnology, Adelaide, Australia)
  • Co-author(s): Alazoni, Abrar (Flinders University, Adelaide, Australia)
    Edwards, Vicki (Flinders University, Adelaide, Australia)
    Jennings, Timothy (Flinders University, Adelaide, Australia)
    Benkendorff, Kirsten (School of Science, Environment and Engineering, University of the Southern Cross, Lismore, Australia)
  • Abstract:

    Background
    Many breast, ovarian & uterine cancers express estrogen receptors (ER) and are stimulated by estrogens (E). E does not stimulate ER+ cell proliferation in in vitro toxicity screening assays currently applied to novel drug candidates, although the in vivo clinical application of ER antagonists prevent tumour growth.
    Dicathis orbita has..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses